These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11932561)

  • 21. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal muscle characteristics and motor performance after 2-year growth hormone treatment in adults with prader-willi syndrome.
    Lafortuna CL; Minocci A; Capodaglio P; Gondoni LA; Sartorio A; Vismara L; Rizzo G; Grugni G
    J Clin Endocrinol Metab; 2014 May; 99(5):1816-24. PubMed ID: 24471571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
    Huseman CA; Colombo JL; Brooks MA; Smay JR; Greger NG; Sammut PH; Bier DM
    Pediatr Pulmonol; 1996 Aug; 22(2):90-5. PubMed ID: 8875581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human growth hormone in the treatment of patients with cystic fibrosis.
    Phung OJ; Coleman CI; Baker EL; Scholle JM; Girotto JE; Makanji SS; Chen WT; Talati R; Kluger J; White CM
    Pediatrics; 2010 Nov; 126(5):e1211-26. PubMed ID: 20921071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
    Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort Study.
    Ting SM; Hamborg T; McGregor G; Oxborough D; Lim K; Koganti S; Aldridge N; Imray C; Bland R; Fletcher S; Krishnan NS; Higgins RM; Townend J; Banerjee P; Zehnder D
    Am J Kidney Dis; 2015 Aug; 66(2):274-84. PubMed ID: 25900597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.
    Radtke T; Hebestreit H; Gallati S; Schneiderman JE; Braun J; Stevens D; Hulzebos EH; Takken T; Boas SR; Urquhart DS; Lands LC; Tejero S; Sovtic A; Dwyer T; Petrovic M; Harris RA; Karila C; Savi D; Usemann J; Mei-Zahav M; Hatziagorou E; Ratjen F; Kriemler S;
    Ann Am Thorac Soc; 2018 Feb; 15(2):209-216. PubMed ID: 29140739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth Hormone Improves Cardiopulmonary Capacity and Body Composition in Children With Growth Hormone Deficiency.
    Capalbo D; Barbieri F; Improda N; Giallauria F; Di Pietro E; Rapacciuolo A; Di Mase R; Vigorito C; Salerno M
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4080-4088. PubMed ID: 28938456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns.
    Suman OE; Thomas SJ; Wilkins JP; Mlcak RP; Herndon DN
    J Appl Physiol (1985); 2003 Jun; 94(6):2273-81. PubMed ID: 12588788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The alterations of body composition in children with growth hormone deficiency during first two years of growth hormone treatment].
    Kucharska AM; Majcher A; Pyrzak B
    Pediatr Endocrinol Diabetes Metab; 2008; 14(3):145-9. PubMed ID: 18922218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users.
    Graham MR; Baker JS; Evans P; Kicman A; Cowan D; Hullin D; Davies B
    Growth Horm IGF Res; 2007 Aug; 17(4):328-35. PubMed ID: 17512232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six minute walk test versus incremental shuttle walk test in cystic fibrosis.
    Saglam M; Vardar-Yagli N; Savci S; Inal-Ince D; Aribas Z; Bosnak-Guclu M; Arikan H; Calik-Kutukcu E; Gunes-Yalcin E
    Pediatr Int; 2016 Sep; 58(9):887-93. PubMed ID: 26756566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.